Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2024Blood Cancer Discovery

Abstract PR07: SETD1B mutations confer apoptosis resistance and BCL2 independence in B-cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

APAna PortelinhaSWShenqiu WangSPSara Parsa

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Portelinha et al. (2024) studied this question.

synapsesocial.com/papers/68e64292b6db6435875d3e63https://doi.org/10.1158/2643-3249.lymphoma24-pr07
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<i>SETD1B</i> mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma2024 · 11 citations
  2. 2Abstract 5698: Exploiting MYC Oncogenic Stress for Therapeutic Benefit in Lymphoma2026
  3. 3Abstract 1857: Mechanisms of acquired resistance to BTK and BCL2 inhibitors reveal clinically actionable vulnerabilities in B-cell lymphoma.2026
  4. 4Abstract 7598: The novel eIF4A inhibitor potently synergizes with BCL2 inhibitor in high grade B-cell lymphoma with MYC and BCL2 rearrangements through regulating UPR2024
  5. 5Abstract 598: CRISPR Cas9 Screens in Mice to Identify Tumor Suppressors of Aggressive Human Lymphoma.2026